Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS research · 2025-07-18

Clinical Trial Update: Corneal Neurotization vs. Cenergermin for Neurotrophic Keratitis: A Pilot Study [NA]

View source ↗

Summary

A pilot clinical trial compares corneal neurotization versus cenegermin for neurotrophic keratitis and is not yet recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Cenergermin (cenegermin)
  • Corneal Neurotization

Snippet

Sponsor: London Health Sciences Centre Research Institute OR Lawson Research Institute of St. Joseph's | Conditions: Neurotrophic Keratitis | NA | Status: NOT_YET_RECRUITING